These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24587997)

  • 1. Contrast media: are there differences in nephrotoxicity among contrast media?
    Solomon R
    Biomed Res Int; 2014; 2014():934947. PubMed ID: 24587997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-osmolality contrast media and the risk of contrast-associated nephrotoxicity.
    Goldfarb S; Spinler S; Berns JS; Rudnick MR
    Invest Radiol; 1993 Nov; 28 Suppl 5():S7-10; discussion S11-2. PubMed ID: 8282507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine.
    Briguori C; Colombo A; Airoldi F; Morici N; Sangiorgi GM; Violante A; Focaccio A; Montorfano M; Carlino M; Condorelli G; Ricciardelli B
    Kidney Int; 2005 Nov; 68(5):2250-5. PubMed ID: 16221226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodinated contrast media and the kidney.
    Weisbord SD
    Rev Cardiovasc Med; 2008; 9 Suppl 1():S14-23. PubMed ID: 18418313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Clinical Factors on Risk of Contrast-Induced Nephrotoxicity From IV Iodinated Low-Osmolality Contrast Material in Patients With a Low Estimated Glomerular Filtration Rate.
    Ellis JH; Khalatbari S; Yosef M; Cohan RH; Davenport MS
    AJR Am J Roentgenol; 2019 Nov; 213(5):W188-W193. PubMed ID: 31268731
    [No Abstract]   [Full Text] [Related]  

  • 6. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate.
    Davenport MS; Khalatbari S; Cohan RH; Dillman JR; Myles JD; Ellis JH
    Radiology; 2013 Sep; 268(3):719-28. PubMed ID: 23579046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media.
    Barrett BJ; Carlisle EJ
    Radiology; 1993 Jul; 188(1):171-8. PubMed ID: 8511292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines.
    Thomsen HS; Morcos SK
    Br J Radiol; 2003 Aug; 76(908):513-8. PubMed ID: 12893691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants.
    Fananapazir G; Troppmann C; Corwin MT; Nikpour AM; Naderi S; Lamba R
    Abdom Radiol (NY); 2016 Nov; 41(11):2182-2186. PubMed ID: 27377897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrotoxicity of low osmolality contrast media versus high osmolality media.
    Steinberg EP; Moore RD; Brinker JA; Fishman EK; Powe NR; Graziano SL; Gopalan R
    Invest Radiol; 1991 Nov; 26 Suppl 1():S86; discussion S88-91. PubMed ID: 1808157
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute kidney failure from the nephrotoxic action of x-ray contrast media].
    Dzgoeva FU; Musselius SG; Kutyrina IM; Zozulia OV; Milovanov IuS
    Urol Nefrol (Mosk); 1996; (1):9-12. PubMed ID: 8659047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality.
    Rudnick MR; Goldfarb S
    Rev Cardiovasc Med; 2003; 4 Suppl 5():S28-33. PubMed ID: 14668707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast medium use.
    Davidson C; Stacul F; McCullough PA; Tumlin J; Adam A; Lameire N; Becker CR;
    Am J Cardiol; 2006 Sep; 98(6A):42K-58K. PubMed ID: 16949380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe?
    Katzberg RW; Newhouse JH
    Radiology; 2010 Jul; 256(1):21-8. PubMed ID: 20574082
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contrast media and percutaneous coronary interventions].
    Aubry P; Halna du Fretay X; Tchetche D
    Ann Cardiol Angeiol (Paris); 2007 Jan; 56(1):2-9. PubMed ID: 17343032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material.
    Davenport MS; Khalatbari S; Dillman JR; Cohan RH; Caoili EM; Ellis JH
    Radiology; 2013 Apr; 267(1):94-105. PubMed ID: 23360737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotoxicity from contrast media: attenuation with theophylline.
    Morcos SK; Brown PW
    Radiology; 1995 Nov; 197(2):546-7; dicussion 248. PubMed ID: 7480713
    [No Abstract]   [Full Text] [Related]  

  • 19. Contrast nephrotoxicity.
    Barrett BJ
    J Am Soc Nephrol; 1994 Aug; 5(2):125-37. PubMed ID: 7993992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.
    Lenhard DC; Pietsch H; Sieber MA; Ernst R; Lengsfeld P; Ellinghaus P; Jost G
    Invest Radiol; 2012 Sep; 47(9):503-10. PubMed ID: 22864374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.